Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma.

Terashima T, Nio K, Koshikawa N, Ueno M, Toyama T, Miyazawa M, Hayashi T, Seki A, Nakagawa H, Iida N, Yamada S, Takatori H, Shimakami T, Yoshimura T, Yoshida E, Nakagawa M, Seiki M, Yamashita T

Open source

DOI
10.1038/s44276-024-00116-z
Published
2025 Jan 14
Container
BJC reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s44276-024-00116-z,
  title = {Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma.},
  author = {Terashima T and Nio K and Koshikawa N and Ueno M and Toyama T and Miyazawa M and Hayashi T and Seki A and Nakagawa H and Iida N and Yamada S and Takatori H and Shimakami T and Yoshimura T and Yoshida E and Nakagawa M and Seiki M and Yamashita T},
  year = {2025},
  journal = {BJC reports},
  doi = {10.1038/s44276-024-00116-z},
  url = {https://doi.org/10.1038/s44276-024-00116-z}
}

RIS

TY  - JOUR
TI  - Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma.
AU  - Terashima T
AU  - Nio K
AU  - Koshikawa N
AU  - Ueno M
AU  - Toyama T
AU  - Miyazawa M
AU  - Hayashi T
AU  - Seki A
AU  - Nakagawa H
AU  - Iida N
AU  - Yamada S
AU  - Takatori H
AU  - Shimakami T
AU  - Yoshimura T
AU  - Yoshida E
AU  - Nakagawa M
AU  - Seiki M
AU  - Yamashita T
PY  - 2025
JO  - BJC reports
DO  - 10.1038/s44276-024-00116-z
UR  - https://doi.org/10.1038/s44276-024-00116-z
ER  - 

APA

T, T., K, N., N, K., M, U., T, T., M, M., T, H., A, S., H, N., N, I., S, Y., H, T., T, S., T, Y., E, Y., M, N., M, S., & T, Y. (2025). Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma.. BJC reports. https://doi.org/10.1038/s44276-024-00116-z

Source records